|
π
|
Association of PD-L1 overexpression with activating EGFR mutations in surgically resected nonsmall-cell lung cancer.
13 auth.
K. Azuma,
K. Ota,
A. Kawahara,
S. Hattori,
E. Iwama,
T. Harada,
Koichiro Matsumoto,
K. Takayama,
S. Takamori,
M. Kage,
...
T. Hoshino,
Y. Nakanishi,
I. Okamoto
|
9 |
2014 |
9
π
|
|
π
|
Induction of PD-L1 Expression by the EML4βALK Oncoprotein and Downstream Signaling Pathways in NonβSmall Cell Lung Cancer
14 auth.
K. Ota,
K. Azuma,
A. Kawahara,
S. Hattori,
E. Iwama,
J. Tanizaki,
T. Harada,
Koichiro Matsumoto,
K. Takayama,
S. Takamori,
...
M. Kage,
T. Hoshino,
Y. Nakanishi,
I. Okamoto
|
8 |
2015 |
8
π
|
|
π
|
Japanese Lung Cancer Registry Study of 11,663 Surgical Cases in 2004: Demographic and Prognosis Changes Over Decade
10 auth.
N. Sawabata,
Etsuo Miyaoka,
H. Asamura,
Y. Nakanishi,
K. Eguchi,
M. Mori,
...
H. Nomori,
Y. Fujii,
M. Okumura,
K. Yokoi
|
8 |
2011 |
8
π
|
|
π
|
Coxsackievirus B3 is an oncolytic virus with immunostimulatory properties that is active against lung adenocarcinoma.
13 auth.
S. Miyamoto,
H. Inoue,
Takafumi Nakamura,
M. Yamada,
C. Sakamoto,
Y. Urata,
T. Okazaki,
Tomotoshi Marumoto,
A. Takahashi,
K. Takayama,
...
Y. Nakanishi,
H. Shimizu,
K. Tani
|
7 |
2012 |
7
π
|
|
π’
|
Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: a meta-analysis.
C. Kiyohara,
K. Takayama,
Y. Nakanishi
|
7 |
2006 |
7
π’
|
|
π’
|
Diagnostic value of CEA and CYFRA 21-1 tumor markers in primary lung cancer.
K. Okamura,
K. Takayama,
M. Izumi,
T. Harada,
Kazuto Furuyama,
Y. Nakanishi
|
7 |
2013 |
7
π’
|
|
π
|
Loss of Suppressor of Cytokine Signaling 1 in Helper T Cells Leads to Defective Th17 Differentiation by Enhancing Antagonistic Effects of IFN-Ξ³ on STAT3 and Smads1
14 auth.
Kentaro Tanaka,
K. Ichiyama,
Masayuki Hashimoto,
H. Yoshida,
T. Takimoto,
G. Takaesu,
T. Torisu,
T. Hanada,
H. Yasukawa,
S. Fukuyama,
...
H. Inoue,
Y. Nakanishi,
Takashi Kobayashi,
A. Yoshimura
|
7 |
2008 |
7
π
|
|
π’
|
The role of high mobility group box1 in pulmonary fibrosis.
9 auth.
N. Hamada,
T. Maeyama,
T. Kawaguchi,
M. Yoshimi,
Jyutaro Fukumoto,
M. Yamada,
...
S. Yamada,
K. Kuwano,
Y. Nakanishi
|
7 |
2008 |
7
π’
|
|
π
|
Pulmonary Resection in Patients Aged 80 Years or Over with Clinical Stage I Non-small Cell Lung Cancer: Prognostic Factors for Overall Survival and Risk Factors for Postoperative Complications
11 auth.
J. Okami,
M. Higashiyama,
H. Asamura,
T. Goya,
Y. Koshiishi,
Y. Sohara,
...
K. Eguchi,
M. Mori,
Y. Nakanishi,
R. Tsuchiya,
Etsuo Miyaoka
|
7 |
2009 |
7
π
|
|
π
|
Suppression of tumor angiogenesis and growth by gene transfer of a soluble form of vascular endothelial growth factor receptor into a remote organ.
8 auth.
K. Takayama,
H. Ueno,
Y. Nakanishi,
T. Sakamoto,
Koji Inoue,
K. Shimizu,
...
H. Oohashi,
Nobuyuki Hara
|
7 |
2000 |
7
π
|
|
π’
|
Randomized Phase III Study Comparing Gefitinib With Erlotinib in Patients With Previously Treated Advanced Lung Adenocarcinoma: WJOG 5108L.
22 auth.
Y. Urata,
N. Katakami,
S. Morita,
R. Kaji,
H. Yoshioka,
T. Seto,
M. Satouchi,
Y. Iwamoto,
M. Kanehara,
D. Fujimoto,
...
N. Ikeda,
H. Murakami,
H. Daga,
T. Oguri,
I. Goto,
F. Imamura,
S. Sugawara,
H. Saka,
N. Nogami,
S. Negoro,
K. Nakagawa,
Y. Nakanishi
|
7 |
2016 |
7
π’
|
